Suspension of trading

Transcripts scPharmaceuticals Inc.

Stocks

SCPH

US8106481059

Pharmaceuticals

Market Closed - Nasdaq 00:00:00 07/10/2025 +04			5-day change	1st Jan Change
5.670 ^USD	-.--%		-.--%	-

07/10/25	MannKind Corporation completed the acquisition of scPharmaceuticals Inc..	CI
07/10/25	MannKind Completes Acquisition of scPharmaceuticals	MT

Transcripts

25/08/25	MannKind Corporation, scPharmaceuticals Inc. - M&A Call
08/08/25	ScPharmaceuticals Inc., Q2 2025 Earnings Call, Aug 07, 2025
15/05/25	ScPharmaceuticals Inc., Q1 2025 Earnings Call, May 14, 2025
20/03/25	ScPharmaceuticals Inc., Q4 2024 Earnings Call, Mar 19, 2025
14/11/24	ScPharmaceuticals Inc., Q3 2024 Earnings Call, Nov 13, 2024
22/10/24	ScPharmaceuticals Inc. - Special Call
15/08/24	ScPharmaceuticals Inc., Q2 2024 Earnings Call, Aug 14, 2024
15/05/24	ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024
14/03/24	ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024
09/11/23	ScPharmaceuticals Inc., Q3 2023 Earnings Call, Nov 08, 2023
11/08/23	ScPharmaceuticals Inc., Q2 2023 Earnings Call, Aug 10, 2023
11/05/23	ScPharmaceuticals Inc., Q1 2023 Earnings Call, May 10, 2023
23/03/23	ScPharmaceuticals Inc., Q4 2022 Earnings Call, Mar 22, 2023
10/11/22	ScPharmaceuticals Inc., Q3 2022 Earnings Call, Nov 09, 2022
09/08/22	ScPharmaceuticals Inc. Provides Earnings Guidance for the Year of 2022	CI
13/07/22	ScPharmaceuticals Inc. - Special Call
16/05/22	ScPharmaceuticals Inc. Provides Earnings Guidance for the Year 2022	CI
22/03/22	Scpharmaceuticals Inc. Provides Earnings Outlook for the Year 2022	CI
14/07/21	scPharmaceuticals Inc. - Special Call
12/05/21	Scpharmaceuticals Inc. Announces Earnings Guidance for 2021	CI
23/03/21	Scpharmaceuticals Inc. Provides Earnings Forecasts for the Year 2021	CI
04/03/21	scPharmaceuticals Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-04-2021 10:30 AM
13/08/20	ScPharmaceuticals Inc. Provides Net Loss Guidance for 2020	CI
09/06/20	scPharmaceuticals Inc. - Shareholder/Analyst Call
18/06/19	scPharmaceuticals Inc. - Shareholder/Analyst Call